1. Anderson FA Jr, Miller RG. ALS CARE: A resource for measuring and improving ALS outcomes. Neurology. 1996;47(Suppl 2):113S -116S
|
|
- Walter Baldwin
- 7 days ago
- Views:
Transcription
1 Bibliography Manuscripts and Book Chapters 1. Anderson FA Jr, Miller RG. ALS CARE: A resource for measuring and improving ALS outcomes. Neurology. 1996;47(Suppl 2):113S -116S 2. Brooks BR. Risk factors in the early diagnosis of ALS: North American epidemiological studies. ALS and Other Motor Neuron Disorders. 2000;1:(Suppl 1) S19-S26 3. Bradley WG, Anderson FA Jr, Bromberg MB, Gutmann L, Harati Y, Ross MA, Miller RG. Current management of ALS: Comparison of the ALS CARE Database and the AAN Practice Parameter. Neurology. 2001;57: Bradley WG, Anderson FA Jr, Gowda NJ, Miller RG and the ALS CARE Study Group. Changes in the management of ALS since the publication of AAN Practice Parameter ALS and Other Motor Neuron Disorders. 2004; 5: Bromberg MB, Anderson FA Jr, Davidson MC, Miller RG, on behalf of the ALS CARE Study Group. Assessing health status quality of life in ALS: Comparison of the SIP/ALS-19 with the ALS Functional Rating Scale and the Short Form-12 Health SurveyTM. ALS and Other Motor Neuron Disorders. 2001;2: Jackson CE, Lovitt S, Gowda N, Anderson FA, Miller RG, and the ALS CARE Study Group: Factors correlated with NPPV use in ALS. Amyotrophic Lateral Sclerosis. June 2006, 7 (2): Lechtzin N, Wiener C, Clawson L, Diette G, Davidson MC, Anderson FA Jr, Gowda N and the ALS CARE Study Group. Use of Non-Invasive Ventilation in Patients with Amyotrophic Lateral Sclerosis. ALS and Other Motor Neuron Disorders Mar;5(1): Mandler RN, Anderson FA Jr, Miller RG, Clawson L, Cudkowicz M, Del Bene M and the ALS CARE Study Group. The ALS Patient Care Database: Insights into end-of-life care in Amyotropic Lateral Sclerosis. ALS and Other Motor Neuron Disorders. 2001; 2: Miller RG, Anderson FA Jr, Bradley WG, Bromberg MB, Brooks BR, Mitsumoto H, Munsat T, Ringel SP, and the ALS CARE Study Group. The ALS Patient Care Database: Goals, design and early results. Neurology. 2000;54(1): Miller RG, Anderson FA Jr. Establishing benchmarks of ALS management. In: Mitsumoto H, Munsat T (eds) Amyotrophic Lateral Sclerosis: A guide for patients and families. Demos Publishing. New York, Mitsumoto H, Davidson MC, Moore D, Gad N, Brandis M, Ringel SP, Rosenfeld J, Shefner J, ALS Bibliography August 11 Page 1
2 Strong M, Sufit R, Anderson FA Jr and the ALS CARE study group. Percutaneous endoscopic Gastrostomy (PEG) in patients with ALS and bulbar dysfunction. ALS and Other Motor Neuron Disorders. 2003; 4; Abstracts and Presentations 12. Anderson FA Jr, Miller RG, and the ALS CARE Advisory Board. The value of databases in ALS: The ALS Patient Care Database experience. Proceedings of the 12th International Symposium on ALS/MND. Oakland, November 18-20, 2001;2 (Suppl 2); abstract:c39; Boynton-De Sepulveda LI. Depressed VS. Non-Depressed ALS patients as a function of time interval since study enrollment. Proceedings of the 12th International Symposium on ALS/MND. Oakland, November 18-20, 2001;2 (Suppl 2); abstractc70; Boynton-De Sepulveda L, Sufit RL, and the ALS CARE Study Group. Identification of psychological well-being and depression in an ALS population and those factors influencing its presentation. Proceedings of the 15th International Symposium on ALS/MND. Philadelphia, Dec 2-4, 2004: 5 (Suppl 2); abstractp138; Brooks BR, Lii J, Huang W, Anderson FA, Miller RG, Mitsumoto H. Epidemiology of Falls in Amyotrophic Lateral Sclerosis Patients: Analysis of Cross-sectional and Prospective Cohorts in the ALS CARE Registry. Proceedings of the 17th International Symposium on ALS/MND. Yokohama, November 30 December 2, 2006: 7(Suppl 1); abstractp154; Brooks BR, Vann JM, Waclawik AJ, Anderson FA Jr and Gowda NJ and the ALS CARE Study Group. Onset of Amyotrophic Lateral Sclerosis [ALS] is delayed, but of course is not altered, in ALS Patients with Pre-Existing Bone and Joint disease: Neuroepidemiological insights from the ALS Care database. Poster Presentation, Neurology, Honolulu, April 1-6, Brooks BR, Anderson FA Jr and Gowda NJ and the ALS CARE Study Group. Amyotrophic Lateral Sclerosis [ALS] outcomes in US military veterans compared with non-veterans: Neuroepidemiological insights from the ALS Patient Care Database. Proceedings of the 14th International Symposium on ALS/MND. Milan, November 16-18, 2003: 4(Suppl 1); abstractc55; Brooks BR, Harati Y, Gowda NJ, Anderson FA Jr, Bradley WG, Mitsumoto H, Miller RG and ALS CARE Study Group United States. Increased Therapeutic Interventions in US Military Veterans with Amyotrophic Lateral Sclerosis (ALS) following Release of American Academy of Neurology (AAN) ALS Practice Parameter (PP): Neuroepidemiological Insights from ALS CARE Database Proceedings of the 15th International Symposium on ALS/MND. Philadelphia, Dec 2-4, 2004: 5 (Suppl 2); abstractc64; Bradley WG, Anderson FA Jr, Bromberg MB, Gutmann L, Harati Y, Ross MA, Miller RG. Discrepancies between recent management practices in ALS and AAN evidence-based practice parameters, as revealed by the ALS Patient Care Database. Proceedings of the 11th International Symposium on ALS/MND. Arhaus, December 4-6, Bradley WG, Anderson FA Jr, Gowda NJ, Bromberg MB, Gutmann L, Harati Y, Ross MA, Miller RG, and the ALS CARE Study Group. Tracking adherence to the ALS practice parameter. Platform presentation, Neurology, Denver, April 13-20, Bradley WG, Anderson FA Jr, Gowda NJ and the ALS CARE Study Group. Improvement in the ALS Bibliography August 11 Page 2
3 management of ALS since 1999 publication of AAN Practice Parameter: Evidence from ALS Patient Care Database. Proceedings of the 14th International Symposium on ALS/MND. Milan, November 16-18, 2003: 4(Suppl 1); abstractc21; Cashman NR, Cudkowicz ME, Davidson MC, Pioro EP, Rosenfeld J, and the ALS CARE Study Group. Gender effects on duration and onset age of Amyotrophic Lateral Sclerosis. Proceedings of the12th International Symposium on ALS/MND. Oakland, November 18-20, 2001;2 (Suppl 2); abstractc60; Cashman NR, White C, Anderson FA Jr, and the ALS CARE Study Group. Gender and presentation age in the ALS Patient Care Database. Neurology. 2000;52(Suppl 2):A Cashman NR, White C, Anderson FA Jr, and the ALS CARE Study Group. Comorbid conditions in patients with Amyotrophic Lateral Sclerosis (ALS) in the ALS Patient Care Database. Proceedings of the 10th International Symposium on ALS/MND. Vancouver, November 8-10, Cashman NR, White C, Anderson FA Jr, and the ALS CARE Study Group. Later presentation age in women in the ALS Patient Care Database. Proceedings of the 10th International Symposium on ALS/MND. Vancouver, November 8-10, Coker L, Donofrio P, Ross MA, Caress J, Hege A, Ashburn C, Walker T, Gowda N and the ALS CARE Study Group. Gender-related differences in spousal caregiving for patients with ALS. Proceedings of the 13th International Symposium on ALS/MND. Melbourne, November 15-17, 2002; Platform Presentation. 27. Cudkowicz M, Graves M, Miller RG, Boyton de Sepulveda L, Lessard D, Davidson MC, Anderson FA Jr, and the ALS CARE Study Group. Effect of Riluzole use on survival, pulmonary and functional status in a cohort of ALS patients. Proceedings of the 11th International Symposium on ALS/MND. Arhaus, December 4-6, Katz JS, Malone SL, Moore DH, Anderson F, Miller RG and the ALS CARE Study Group. Regional differences between long and short survivors in ALS. Proceedings of the 16 th International Symposium on ALS/MND, Dublin, December 8-10, Amyotrophic Lateral Sclerosis (Suppl 1); 6: Lechtzin N. Respiratory interventions for ALS: Predictors of use and outcomes. Annual Meeting of the American Thoracic Society. May Lechtzin N, Moore D, Miller RG, Mitsumoto H, Brooks BR, Anderson FA Jr, Gowda NJ and the ALS CARE study group. Noninvasive Positive Pressure Ventilation Use and Outcomes in Patients with Amyotrophic Lateral Sclerosis. Proceedings of the 15th International Symposium on ALS/MND. Philadelphia, Dec 2-4, 2004: SESSION 10B: 5(Suppl 2); abstractc88; Mandler RN, Clawson L, Miller RG, and the ALS CARE Study Group. The ALS Patient Care Database: Insights into end-of-life palliative care in Amyotropic Lateral Sclerosis. Ann Neurol. 1999;46(3): Mandler RN, Clawson L, and the ALS CARE Study Group. The ALS Patient Care Database: Caregivers perspective on effectiveness of palliative care. Proceedings of the 9th International Symposium on ALS/MND. Munich, November 16-18, 1998 ALS Bibliography August 11 Page 3
4 33. Miller RG, Anderson F, Bradley W, Brooks BR, Mitsumoto H and the ALS CARE study group. Temporal Trends in the care of patients with ALS North American ALS CARE Database. Proceedings of the 17th International Symposium on ALS/MND. Yokohama, November 30 December 2, 2006 Oral Presentation 34. Miller RG, Anderson FA Jr, Bradley WG, Brooks BR, Mitsumoto H, Munsat TL, Ringel, SP, and the ALS CARE Study Group. The ALS Patient Care Database: A resource for measuring and improving ALS outcomes. Neurology. 1998;50(Suppl 4):A Miller RG, Bromberg MB, Anderson FA Jr, and the ALS CARE Study Group. Assessing the quality of life in ALS: Comparison of the Short Form-12 Health Survey with the ALS Functional Rating Scale, forced vital capacity and ALS Quality of Life Index. Proceedings of the 8th International Symposium on ALS/MND. Glasgow, November 2-4, Miller, RG. The ALS Patient Care Database: Outcomes assessment in practice. Proceedings of the 9th International Symposium on ALS/MND. Munich, November 16-18, Miller, RG, Mitsumoto H, Bradley WG, Gowda NJ, and Anderson FA Jr and the ALS CARE Study Group. Temporal trends in the care of ALS in North America: Proceedings of the 15th International Symposium on ALS/MND. Philadelphia, Dec 2-4, Session 8B: 5(Suppl 2); abstractc62; Mitsumoto H, Bradley WG. Treatment of ALS: Practice guidelines and outcomes assessment. Neurology. 1999;52(Suppl 1): Mitsumoto H, Davidson MC, Moore D, Brandis M, Del Bene M, Cashman NR, Ringel SP, Rosenfeld J, Shefner J, Strong M, Anderson FA Jr. PEG utilization in participants of the ALS Patient Care Database. Neurology. 2001;56(Suppl 3): A Mitsumoto H, Anderson FA Jr, Albert S, Gowda N, Miller R, Rosenfeld J, Strong M, Bromberg M and the ALS CARE study group. Improving end of life care in ALS: Findings from the ALS CARE database. Proceedings of the 15th International Symposium on ALS/MND. Philadelphia, Dec 2-4, 2004: SESSION 8B: 5(Suppl 2); abstractc63; Moore DH, Miller RG, Cudkowicz M, Kaufmann P, Huang W, Anderson FA, Western ALS group, Northeastern ALS group, ALS CARE study group. Development and Validation of a Staging System for ALS. Proceedings of the 15th International Symposium on ALS/MND 2004; 5(Suppl 2); abstractp107; Pioro EP, Malone S, Anderson FA. Atypical features in patients with ALS and their impact on caregiver burden: Findings from the ALS Patient CARE database. Proceedings of the 16 th International Symposium on ALS/MND, Dublin, December 8-10, Amyotrophic Lateral Sclerosis (Suppl 1); 6: Rosenfeld J. Multidisciplinary versus solo practitioner care of the ALS patient. Proceedings of the 11th International Symposium on ALS/MND. Arhaus, December 4-6, Ross MA, Bradley WG, Heinman-Patterson T, Lyon M, Singleton C, Lessard D. The ALS caregiver Insights from the ALS Patient Care Database. Proceedings of the 10th International Symposium on ALS/MND. Vancouver, November 8-10, 1999 ALS Bibliography August 11 Page 4
5 45. Ross MA, Bryan W, Hoagland R, Brooks BR, Harati Y, Parry G, Miller RG, and the ALS CARE Study Group. Application of the El Escorial ALS diagnostic criteria in clinical practice. Neurology. 1999;52(6) Suppl 2:A Ross MA, Bradley WG, Heinman-Patterson T, Lyon M, Gowda NJ, Anderson FA, Dabbous OH, Moore DH and the ALS CARE Study Group. The ALS caregiver New Insights from the ALS Patient Care Database. Proceedings of the 14th International Symposium on ALS/MND. Milan, November 16-18, 2003: 4(Suppl 1); abstractc22; Sufit RL, Miller RG, Mitsumoto H, Parry G, Ringel SP, Lessard D, and the ALS CARE Study Group. Prevalence and treatment of sialorrhea in Amyotrophic Lateral Sclerosis patients as assessed by the ALS Patient Care Database. Ann Neurol. 1999;46(3):506 ALS Bibliography August 11 Page 5
Amyotrophic Lateral Sclerosis Performance Measurement Set
APPROVED FOR CITATION American Academy of Neurology Amyotrophic Lateral Sclerosis Performance Measurement Set Status: AAN BOARD OF DIRECTORS APPROVED 7.31.2012 1 APPROVED FOR CITATION Physician Performance
Spinal Muscular Atrophy
Maryam Oskoui, MD, MSc, FRCPC Pediatric Neurologist Spinal Muscular Atrophy Elise Historical Timeline In vitro and animal studies Werdnig and Hoffmann describe SMA 1 (Arch Psych Nervenkrankheiten) Disease
Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy
Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Judith Long, MD,RWJCS Perelman School of Medicine Philadelphia Veteran Affairs Medical Center Background Objective Overview Methods
TREATMENT FOR ALS - EVIDENCE BASED MANAGEMENT
TREATMENT FOR ALS - EVIDENCE BASED MANAGEMENT Robert G. Miller, MD California Pacific Medical Center San Francisco, CA ALS is a steadily progressive disease resulting in death on average within 3 years.
Update: The Care of the Patient with Amyotrophic Lateral Sclerosis
Update: The Care of the Patient with Amyotrophic Lateral Sclerosis Case Presentation: Part I A 54-year-old woman presents to the neurology clinic referred by her primary care physician for evaluation of
Nutrition support in neurodegenerative diseases
ESPEN Congress Leipzig 2013 The ESPEN Guidelines session Nutrition support in neurodegenerative diseases R. Burgos (ES) ESPEN GUIDELINES ON NUTRITION SUPPORT IN NEURODEGENERATIVE DISORDERS Dr. Rosa Burgos
Long-term benefits of galantamine (Reminyl ) in Alzheimer s disease. Michael Gold 1, Sean Lilienfeld 2, & Luc Truyen 1
Long-term benefits of galantamine (Reminyl ) in Alzheimer s disease Michael Gold 1, Sean Lilienfeld 2, & Luc Truyen 1 1 Johnson & Johnson Pharmaceutical Research and Development, Titusville, New Jersey
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest Cycle C June 2, 2015 1 Introduction The landscape for the treatment of relapsing Multiple Sclerosis (MS) has quickly evolved over
Guidelines for Medical Necessity Determination for Speech and Language Therapy
Guidelines for Medical Necessity Determination for Speech and Language Therapy These Guidelines for Medical Necessity Determination (Guidelines) identify the clinical information MassHealth needs to determine
Guidelines for Medical Necessity Determination for Occupational Therapy
Guidelines for Medical Necessity Determination for Occupational Therapy These Guidelines for Medical Necessity Determination (Guidelines) identify the clinical information MassHealth needs to determine
NESDA is supported by the ZonMW Geestkracht program, which is intended to promote collaboration between disciplines and institutes.
NESDA ANALYSIS PLAN Please fax, send or e-mail completed form to Marissa Kok, NESDA study, A.J. Ernststraat 1187, 1081 HL Amsterdam. Fax: 020-788 5664. E-mail: ma.kok@ggzingeest.nl NESDA is supported by
Fatigue in MS: 2005 update B. Colombo University of Milan - HSR
Fatigue in MS: 2005 update B. Colombo University of Milan - HSR Fatigue in MS One of the more disabling symptoms Affects about 75/90 % of the patients May be the onset symptom Transient or chronic May
Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data
Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data Prepared for the 138th Annual Meeting of the American Public Health Association Denver, CO
Appendix E Table of Contents
Table of Contents Costs, Access to Resources and Health Policy 1 Tools and Resources 5 Access to Resources 6 Identification of Existing Gaps 13 Recommendations to the Field 17 Access to Quality Care Cost
PHYSICAL THERAPY INTERVENTION WITH ALS
PHYSICAL THERAPY INTERVENTION WITH ALS Richard W. Briggs MA, PT Chair, APTA Hospice and Palliative Care SIG Amyotrophic Lateral Sclerosis (ALS) provides a challenge to those physical therapists charged
The topics covered in this section are: Who gets MND? Causes of MND Treatments available The effects of MND. The different names for MND
The topics covered in this section are: The different names for MND Who gets MND? Causes of MND Treatments available The effects of MND The different names for MND In the USA, MND is referred to as Amyotrophic
MULTIMODAL THERAPY FOR MS- ASSOCIATED COGNITIVE DYSFUNCTION
MULTIMODAL THERAPY FOR MS- ASSOCIATED COGNITIVE DYSFUNCTION Michael K. Racke, MD Professor and Chairman in Neurology The Helen C. Kurtz Chair in Neurology Department of Neurology Ohio State University
Calendar of events NEUROLOGY
Calendar of events 2016 NEUROLOGY Rome, Italy 29 January 2016 Updates on MS treatment management Project an individualized treatment plan in MS Explain how to manage patients day to day issues List the
International Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014
International Journal of Economics, Commerce and Management United Kingdom Vol. II, Issue 2, 2014 http://ijecm.co.uk/ ISSN 2348 0386 HEALTHCARE MANAGEMENT AND PSYCHOLOGICAL WELL-BEING IN PATIENTS WITH
Information for professionals when making end of life treatment decisions with patients with Motor Neurone Disease (MND)
Information for professionals when making end of life treatment decisions with patients with Motor Neurone Disease (MND) Recognising the dying process allows the patient, their family and professionals
Unmet Needs for Parkinson s Disease Therapeutics
Unmet Needs for Parkinson s Disease Therapeutics Coalition Against Major Diseases & FDA Workshop October 20, 2014 Caroline M Tanner MD, PhD Director, Parkinson's Disease Research Education and Clinical
Rates and Predictors of Progression from Mild Cognitive Impairment to Dementia: The Mayo Clinic Study of Aging
Rates and Predictors of Progression from Mild Cognitive Impairment to Dementia: The Mayo Clinic Study of Aging 11 th Annual Mild Cognitive Impairment Symposium January 19th, 2013 Rosebud Roberts, M.B.
Pulmonary Rehabilitation in Ontario: OHTAC Recommendation
Pulmonary Rehabilitation in Ontario: OHTAC Recommendation ONTARIO HEALTH TECHNOLOGY ADVISORY COMMITTEE MARCH 2015 Pulmonary Rehabilitation in Ontario: OHTAC Recommendation. March 2015; pp. 1 13 Suggested
EMG in Motor Neuron Disease. Randall L. Braddom, M.D., M.S.
EMG in Motor Neuron Disease Randall L. Braddom, M.D., M.S. rlbraddom@comcast.net Definition Motor Neuron Diseases are diseases or conditions that produce dysfunction of the anterior horn cells, which then
Approved: Acute Stroke Ready Hospital Advanced Certification Program
Approved: Acute Stroke Ready Hospital Advanced Certification Program The Joint Commission recently developed a new Disease- Specific Care Advanced Certification program for Acute Stroke Ready Hospitals
IBADAN STUDY OF AGEING (ISA): RATIONALE AND METHODS. Oye Gureje Professor of Psychiatry University of Ibadan Nigeria
IBADAN STUDY OF AGEING (ISA): RATIONALE AND METHODS Oye Gureje Professor of Psychiatry University of Ibadan Nigeria Introduction The Ibadan Study of Ageing consists of two components: Baseline cross sectional
MILESTONES. European Register for Multiple Sclerosis - a Tool to Assess, Compare and Enhance the Status of People with MS throughout
European Register for Multiple Sclerosis - a Tool to Assess, Compare and Enhance the Status of People with MS throughout the EU MILESTONES 2011 2012 Project co-funded by the Public Health Program of the
Measure Title FOLLOW UP EXAMINATION AFTER DIAGNOSIS AND TREATMENT OF SKIN CANCERS Disease State Cancer Indicator Classification Disease Management
Client HMSA: PQSR 2009 Measure Title FOLLOW UP EXAMINATION AFTER DIAGNOSIS AND TREATMENT OF SKIN CANCERS Disease State Cancer Indicator Classification Disease Management Strength of Recommendation Organizations
MS Nurse PROfessional
MS Nurse PROfessional The first and only European accredited MS nurse training curriculum www.msnursepro.org Available in EIGHT languages This activity is supported by educational grants from: Founding
Dementia Episodes of Care
A Guide for Bundled Payments This document reviews the considerations in establishing a bundled payment program for services provided to patients with dementia. In addressing dementia, there are two distinct
Program Outcome Summary Grant #8458 (Draft)
Promoting Resilience in Multiple Sclerosis Patients Program Outcome Summary Grant #8458 (Draft) Richard Lewis, PharmD, MBA Executive Director, ProCE, Inc. Office: (630) 540-2917 RLewis@ProCE.com Prepared
Medical Coverage Policy Monitored Anesthesia Care (MAC)
Medical Coverage Policy Monitored Anesthesia Care (MAC) Device/Equipment Drug Medical Surgery Test Other Effective Date: 9/1/2004 Policy Last Updated: 1/8/2013 Prospective review is recommended/required.
Reversibility of Acute Demyelinating Lesions in relapsingremitting
Reversibility of Acute Demyelinating Lesions in relapsingremitting Multiple Sclerosis Omar A. Khan ( Division of Neuroimmunology, Department of Neurology, Neurology and Research Services. Veterans Affairs
Quality Improvement in Primary Care Settings
Quality Improvement in Primary Care Settings Eboni Price Haywood, MD, MPH Chief Medical Officer, Tulane Community Health Medical Director, Tulane Community Health @ Covenant House Team Approach to Quality
REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD
REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD What is Rehabilitation Medicine? Rehabilitation Medicine (RM) is the medical specialty with rehabilitation as its primary strategy. It provides services
Health Care Decision Making Worksheet. Instructions
Health Care Decision Making Worksheet Instructions Use this worksheet either to indicate current treatment preferences (which will be reflected in Maryland MOLST orders) or to clarify wishes for future
Hospice Palliative Care Program Symptom Guidelines. Amyotrophic Lateral Sclerosis (ALS)
Hospice Palliative Care Program Symptom Guidelines Amyotrophic Lateral Sclerosis (ALS) Amyotrophic Lateral Sclerosis (ALS) Rationale This guideline is adapted for inter-professional primary care providers
M ultiple sclerosis (MS) is the most common cause of
20 PAPER The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment E L J Hoogervorst, P de Jonge, B Jelles, F J Huyse, I Heeres, H M van der Ploeg,
When is Memory Loss Significant? David Williamson, PhD (ABPP-Cn), MBA
When is Memory Loss Significant? David Williamson, PhD (ABPP-Cn), MBA Third Annual Neuroscience Symposium Orange Beach, AL April 2016 Disclosures Dr. Williamson is an employee of Janssen Scientific Affairs,
CURRENT TOPICS IN CARE MANAGEMENT. Interactive and Practical Workshops for Care Managers
CURRENT TOPICS IN CARE MANAGEMENT Interactive and Practical Workshops for Care Managers TABLE OF CONTENTS Tap the title to go directly to that section. Program Overview....3 Who Should Attend Why Attend
Time-related bias in administrative health database studies of disease incidence
eappendix TITLE Time-related bias in administrative health database studies of disease incidence OBJECTIVE To illustrate the bias resulting from temporal aspects of administrative health databases and
As you know, the CPT Editorial Panel developed two new codes to describe complex ACP services for CY 2015.
December 30, 2014 SUBMITTED ELECTRONICALLY VIA http://www.regulations.gov Marilyn Tavenner Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS
Melanie Atmadja, Valerie Gribben, Noga Ravid Developmental and Behavioral Pediatrics April 23, 2013
Mortality, ADHD, and Psychosocial Adversity in Adults with Childhood ADHD: A Prospective Study WJ Barbaresi, RC Colligan, AL Weaver, RG Voigt, JM Killian and SK Katusic. Pediatrics 2013;131;637; originally
Adult Spine Rotation Specific Evaluation Orthopaedic Surgery Training Program School of Medicine, Queen s University
Adult Spine Rotation Specific Evaluation Orthopaedic Surgery Training Program School of Medicine, Queen s University CanMEDS Roles / Competencies Name: PGY Rotation Dates: s s Exceeds N/A Attending Staff:
Innovative Digital Patient Recruitment Strategies in Prodromal Alzheimer s Disease Trials
INSIGHT BRIEF Innovative Digital Patient Recruitment Strategies in Prodromal Alzheimer s Disease Trials Lynne Hughes, B.Med.Sci., PhD., PMP, Vice President & Therapeutic Strategy Head, Neurology, Global
CENTER FOR KLINISKE RETNINGSLINJER - CLEARINGHOUSE
Bilag 2 - Søgematricer Medline Træning amyotrophic lateral upper motor neuron disease Amyotrophic lateral sclerosis [MeSH] physical fitness [MeSH] physical training exercise therapy [MeSH] Rehabilitation
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative
Spirometry in the Supine Position Improves the Detection of Diaphragmatic Weakness in Patients With Amyotrophic Lateral Sclerosis* Noah Lechtzin, MD, MHS; Charles M. Wiener, MD, FCCP; David M. Shade, BA,
Screening, Brief Intervention, and Referral for Treatment: Evidence for Use in Clinical Settings: Reference List
Screening, Brief Intervention, and Referral for Treatment: Evidence for Use in Clinical Settings: Reference List Elinore F. McCance Katz, MD, PhD Professor of Psychiatry University of California San Francisco
Three triggers for Supportive/ Palliative Care are suggested - to identify these patients we can use any combination of the following methods:
Three triggers for Supportive/ Palliative Care are suggested - to identify these patients we can use any combination of the following methods: 1. The surprise question Would you be surprised if this patient
Intrathecal Baclofen for CNS Spasticity
Intrathecal Baclofen for CNS Spasticity Last Review Date: November 13, 2015 Number: MG.MM.ME.31bC5 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or
Medical Cannabis Program Update
OFFICE OF MEDICAL CANNABIS Medical Cannabis Program Update APRIL 216 Minnesota s medical cannabis program began distributing medical cannabis to registered patients on July 1, 215. This update reports
chapter 3.1 Chapter 3.1 Clinical scales in progressive MS: predicting long-term disability LVAE Bosma, JJ Kragt, DL Knol, CH Polman, BMJ Uitdehaag
chapter 3.1 Chapter 3.1 Clinical scales in progressive MS: predicting long-term disability LVAE Bosma, JJ Kragt, DL Knol, CH Polman, BMJ Uitdehaag Multiple Sclerosis 2012;18:345-350 Chapter 3.1 Abstract
Neural Diagnostics Pty Ltd
Neural Diagnostics Pty Ltd EVestG (ElectroVestibulography) In the absence of competing technology, research to date indicates NDPL s EVestG platform technology can objectively and in real time: o Separate
BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 bps@aphanet.org www.bpsweb.
BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 bps@aphanet.org www.bpsweb.org Content Outline for the PSYCHIATRIC PHARMACY SPECIALTY
Prolonged Mechanical Ventilator Weaning: Experience from Ontario
Prolonged Mechanical Ventilator Weaning: Experience from Ontario Louise Rose Lawrence S. Bloomberg Professor in Critical Care Nursing, University of Toronto Director of Research, Provincial Centre of Weaning
Q10: For carers of people with dementia, does respite care when compared to care as usual, produce benefits/harm in the specified outcomes?
updated 2012 Respite care for carers of people with dementia Q10: For carers of people with dementia, does respite care when compared to care as usual, produce benefits/harm in the specified outcomes?
The Interface Between Sleep Apnea and Seizures. Hrayr Attarian M.D. Northwestern University Feinberg School of Medicine.
The Interface Between Sleep Apnea and Seizures Hrayr Attarian M.D. Northwestern University Feinberg School of Medicine. What is Sleep Apnea? Obstructive sleep apnea syndrome (OSA) is characterized by repeated
Three triggers that suggest that patients could benefit from a hospice palliative care approach
Why is it important to identify people nearing the end of life? About 1% of the population dies each year. Although some deaths are unexpected, many more in fact can be predicted. This is inherently difficult,
Thesis: Prevalence and Correlates of Exercise Motivated by Negative Affect Chair: Drew Anderson, PhD
Kyle Patrick De Young, MA Home: (312) 339-4202 Office: (518) 437-4446 Email: kd897738@albany.edu Curriculum Vitae University at Albany, State University of New York Department of Psychology 1400 Washington
Barriers to Care Coordination. Pitfalls. Ineffective Transitions Lead to Poor Outcomes
Eliminating the Pitfalls and Barriers to Reducing Rehospitalizations Evelyn Thompson RN,CMC Director of Care Transitions Genesis Healthcare October 2013 Barriers to Care Coordination System level barriers
STATE OF NEBRASKA STATUTES RELATING TO RESPIRATORY CARE PRACTICE ACT
2012 STATE OF NEBRASKA STATUTES RELATING TO RESPIRATORY CARE PRACTICE ACT Department of Health and Human Services Division of Public Health Licensure Unit 301 Centennial Mall South, Third Floor PO Box
Caregiving Impact on Depressive Symptoms for Family Caregivers of Terminally Ill Cancer Patients in Taiwan
Caregiving Impact on Depressive Symptoms for Family Caregivers of Terminally Ill Cancer Patients in Taiwan Siew Tzuh Tang, RN, DNSc Associate Professor, School of Nursing Chang Gung University, Taiwan
Weight Management Programme
Weight Management Programme Weight loss surgery can help to improve your health and general well being College Road, Cork BON SECOURS HOSPITAL 1 Tel: 021-4542807 Fax: 021 4542350 www.bonsecours.org/ie/cork/index.html
ROCKY MOUNTAIN MULTIPLE SCLEROSIS CENTER:
Curriculum Vitae PATRICIA M. KENNEDY 16095 B Double Eagle Drive Morrison, CO 80465 303-697-6586 970-926-1283office email address: pkennedy@mscando.org EXPERIENCE Can Do Multiple Sclerosis, formerly The
FSH Society s 2014 Biennial FSHD Connect Meeting: Natural History Studies
FSH Society s 2014 Biennial FSHD Connect Meeting: Natural History Studies Raymond A. Huml, MS, DVM, RAC Executive Director, Head, Global Biosimilars Business Development and Strategic Planning, Quintiles
Evidence-Based Practice Guidelines for the Management of Communication Disorders in Neurologically Impaired Individuals: Project Introduction
Evidence-Based Practice Guidelines for the Management of Communication Disorders in Neurologically Impaired Individuals: Project Introduction Prepared by: The Academy of Neurologic Communication Disorders
ALS and Lyme Disease Questions from Patient and Families Responses from Medical Experts
ALS and Lyme Disease Questions from Patient and Families Responses from Medical Experts Introduction: When anyone receives a diagnosis of ALS, it is normal and understandable to ask why you ve developed
Being PRO-ACTive: A Collaborative Effort to Bring Big Data to ALS. Alex Sherman, Melanie Leitner, Prize4Life
Being PRO-ACTive: A Collaborative Effort to Bring Big Data to ALS Alex Sherman, NCRI@MGH Melanie Leitner, Prize4Life What is ALS (Lou Gehrig s Disease)? Orphan disease 100% lethal within 2-5 years from
Management of Pacing Wires After Cardiac Surgery
Management of Pacing Wires After Cardiac Surgery David E. Lizotte, Jr. PA C, MPAS, FAPACVS President, Association of Physician Assistants in Cardiovascular Surgery Conflicts: None Indications 2008 Journal
Multiple Sclerosis (MS) Aprile Royal, Novartis Pharma Canada Inc. September 21, 2011 Toronto, ON
Multiple Sclerosis (MS) Aprile Royal, Novartis Pharma Canada Inc. September 21, 2011 Toronto, ON First-line DMTs Reduce Relapse Frequency by ~30% vs. Placebo Frequency of relapse with various DMTs, based
BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 info@bpsweb.org www.bpsweb.
BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC 20037-2985 202-429-7591 FAX 202-429-6304 info@bpsweb.org www.bpsweb.org Content Outline for the CRITICAL PHARMACY SPECIALTY CERTIFICATION
The Development of an APN Led Post Cancer Treatment Follow-Up Clinic
The Development of an APN Led Post Cancer Treatment Follow-Up Clinic Shari Moura RN MN CON(C) CHPCN(C) Advanced Practice Nurse After Cancer Treatment Transition Clinic WCH-PMH ACTT Clinic CANO/ACIO Annual
The American Society of Anesthesiologists (ASA) has defined MAC as:
Medical Coverage Policy Monitored Anesthesia Care (MAC) sad EFFECTIVE DATE: 09 01 2004 POLICY LAST UPDATED: 11 04 2014 OVERVIEW The intent of this policy is to address anesthesia services for diagnostic
Achieving Quality and Value in Chronic Care Management
The Burden of Chronic Disease One of the greatest burdens on the US healthcare system is the rapidly growing rate of chronic disease. These statistics illustrate the scope of the problem: Nearly half of
Research of influence factors on the quality of life of 121 patients with rectal cancer
2015 28 6 http / /www. psychjm. net. cn 121 2013 12-2014 12 121 QLQ - 30 HAMD HAMA 42 34. 71% 10 ICD - 10 38 31. 40% P < 0. 05 P < 0. 05 P < 0. 05 P < 0. 05 P < 0. 05 GQL PF HAMD RF CF HAMA HAMD EF SF
Major Depressive Disorder:
Major Depressive Disorder: An Actuarial Commercial Claim Data Analysis July 2013 Prepared by: Milliman, Inc. NY Kate Fitch RN, MEd Kosuke Iwasaki FIAJ, MAAA, MBA This report was commissioned by Takeda
Motor Neurone Disease Services for Western Australia
Neurosciences & the Senses Health Network Motor Neurone Disease Services for Western Australia Prepared by the Motor Neurone Disease Project Group Neurosciences & the Senses Health Network May 2008 Health
State of the Nation: An overview of the impact and priorities for lung cancer in Northern Ireland
State of the Nation: An overview of the impact and priorities for lung cancer in Northern Ireland Introduction Lung cancer is Northern Ireland s biggest cancer killer. It causes more than one in five of
Current Research & Innovations in TBI Follow-up from the Defense & Veterans Brain Injury Center (DVBIC, Palo Alto)
Current Research & Innovations in TBI Follow-up from the Defense & Veterans Brain Injury Center (DVBIC, Palo Alto) John H. Poole, PhD VA Health Care System, Palo Alto, California North American Brain Injury
Appendix A - Low Back Pain Scope
Appendix A - Low Back Pain Scope Low back pain: full guideline DRAFT (September 2008) Page 1 of 10 NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Low back pain: the acute
Breaking Down the Barriers - Masterclass training package and modules
Breaking Down the Barriers - Masterclass training package and modules Assessment of a patient with urgent mental health needs in an emergency department Module 1 Module 2 Mental health awareness training
Focus on the Care of Chronic Pain in the Elderly. Proposal: The Rights of Citizens Over 65 with Chronic Pain
INDEX Assumption Overview on a European Union Level Focus on the Care of Chronic Pain in the Elderly Definition Epidemiology and Social Impact Critical Points Proposal: The Rights of Citizens Over 65 with
Does referral from an emergency department to an. alcohol treatment center reduce subsequent. emergency room visits in patients with alcohol
Does referral from an emergency department to an alcohol treatment center reduce subsequent emergency room visits in patients with alcohol intoxication? Robert Sapien, MD Department of Emergency Medicine
How much data is enough? Data prioritisation using analytics
How much data is enough? Data prioritisation using analytics ABOUT BIZDATA Established in 2005 Experts in Data Management and Business Intelligence Have delivered over 200 projects Provide services to
Challenges in Developing Therapeutics in Partially Responsive and Treatment Resistant Depression Where do we go from here?
Challenges in Developing Therapeutics in Partially Responsive and Treatment Resistant Depression Where do we go from here? Heddie Martynowicz, MS Senior Director, Global Regulatory Affairs Janssen R &
Care Considerations In Duchenne Muscular Dystrophy
Care Considerations In Duchenne Muscular Dystrophy Susan L. Kerr, MD; Associate Professor of Clinical Neurology Nicholas J. Silvestri, MD; Clinical Assistant Professor of Neurology Daniel W. Sheehan, PhD,
The Hunter Outcome Survey (HOS) a Valuable Disease Registry. Maria Paabøl Larsen Associate Director for HOS Shire HGT
The Hunter Outcome Survey (HOS) a Valuable Disease Registry Maria Paabøl Larsen Associate Director for HOS Shire HGT ECRD, May 2012 Disclosures The Hunter Outcome Survey is funded by Shire HGT Maria Paabøl
Supplementary Online Content
Supplementary Online Content Burt RK, Balabanov R, Han X, et al. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting
Chemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015
Chemobrain Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Terminology Chemotherapy-associated cognitive dysfunction Post-chemotherapy cognitive impairment Cancer treatment-associated cognitive
Home Dialysis Benchmarks Workgroup. Peritoneal Dialysis (PD)
Home Dialysis Benchmarks Workgroup Peritoneal Dialysis (PD) Medical Knowledge Fellows must demonstrate knowledge of established and evolving biomedical, clinical, epidemiological and social behavioral
Sex Differences in Multiple Sclerosis: Clinical, Imaging, and Pathology
Sex Differences in Multiple Sclerosis: Clinical, Imaging, and Pathology Sex Differences and Implications for Translational Neuroscience Research A Workshop Forum on Neuroscience and Nervous System Disorders
ALS in the Military ALS IN THE MILITARY UNEXPECTED CONSEQUENCES OF MILITARY SERVICE. February 4, 2013
ALS IN THE MILITARY UNEXPECTED CONSEQUENCES OF MILITARY SERVICE February 4, 2013 May 16, 2007 1 INTRODUCTION Seventy years ago, baseball legend Lou Gehrig gave his name to a mysterious and rare disease
Pragmatic Evidence Based Review Substance Abuse in moderate to severe TBI
Pragmatic Evidence Based Review Substance Abuse in moderate to severe TBI Reviewer Emma Scheib Date Report Completed November 2011 Important Note: This report is not intended to replace clinical judgement,
b. Distinguish between different venues of senior residence c. Advocate the necessity of geriatrics as a true specialty
1. Introduction/ Getting to know our Seniors a. Identify common concepts and key terms used when discussing geriatrics b. Distinguish between different venues of senior residence c. Advocate the necessity
Disease Management Identifications and Stratification Health Risk Assessment Level 1: Level 2: Level 3: Stratification
Disease Management UnitedHealthcare Disease Management (DM) programs are part of our innovative Care Management Program. Our Disease Management (DM) program is guided by the principles of the UnitedHealthcare
Post Traumatic Stress Disorder (PTSD) Karen Elmore MD Robert K. Schneider MD Revised 5-11-2001 by Robert K. Schneider MD
Post Traumatic Stress Disorder (PTSD) Karen Elmore MD Robert K. Schneider MD Revised 5-11-2001 by Robert K. Schneider MD Definition and Criteria PTSD is unlike any other anxiety disorder. It requires that
Chronic Disease and Nursing:
Chronic Disease and Nursing: A Summary of the Issues What s the issue? Chronic diseases are now the major global disease problem facing the world and a key barrier to development, to alleviating poverty,
EBM Cheat Sheet- Measurements Card
EBM Cheat Sheet- Measurements Card Basic terms: Prevalence = Number of existing cases of disease at a point in time / Total population. Notes: Numerator includes old and new cases Prevalence is cross-sectional
The Impact of Palliative Care and Hospice Services in the Care of Patients with Advanced Stage Non-Small Cell Lung Cancer
The Impact of Palliative Care and Hospice Services in the Care of Patients with Advanced Stage Non-Small Cell Lung Cancer Richard C. Stephenson, MD Hospice & Palliative CareCenter Amy H. Hughes Forsyth
WAC Pain management Intent. These rules govern the use of opioids in the treatment of patients for chronic noncancer pain.
WAC 246-853-660 Pain management Intent. These rules govern the use of opioids in the treatment of patients for chronic noncancer pain. WAC 246-853-661 Exclusions. The rules adopted under this section do